/Companies

Freya Biosciences

6 known investors

Find your way into Freya Biosciences

Sign up to see every warm intro you have to Freya Biosciences

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Freya Biosciences team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Freya Biosciences develops innovative therapies targeting immune-mediated diseases that affect women. The company is led by a team with extensive experience in bringing therapeutic drugs to market from major pharmaceutical companies.

Founders & leadership

CA
Colleen Acosta, PhDCEO, Co-Founder
JV
Johan van Hylckama Vlieg, PhDCSO, Co-Founder

Investors · 6

Also in the syndicate · 1

EIFO

Funding

SEC filings, press & company announcements

$38M disclosed across 1 of 2 rounds · 2023–2024

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Freya Biosciences do?
Freya Biosciences develops innovative therapies targeting immune-mediated diseases that affect women. The company is led by a team with extensive experience in bringing therapeutic drugs to market from major pharmaceutical companies.
Who founded Freya Biosciences?
Freya Biosciences was founded by Colleen Acosta, PhD, Johan van Hylckama Vlieg, PhD.
Who are Freya Biosciences's investors?
Freya Biosciences's investors include Angelini Ventures, Indaco Venture Partners, OMX Ventures, Sofinnova Partners, Bill & Melinda Gates Foundation.
How much funding has Freya Biosciences raised?
Freya Biosciences has disclosed $38M raised across 1 of its 2 known rounds.